Breast Cancer Research and Treatment

, Volume 122, Issue 1, pp 95–104 | Cite as

Unfavourable clinicopathologic features and low response rate to systemic adjuvant therapy: results with regard to poor survival in young Chinese breast cancer patients

  • Li-Chen Tang
  • Wen-Jin Yin
  • Gen-Hong Di
  • Zhen-Zhou Shen
  • Zhi-Ming Shao
Preclinical study
First Online:
Received:
Accepted:

Abstract

The prognostic factors of young breast cancer patients (BCPs) are still controversial. This study is aimed at evaluating the prognosis of young BCPs by characteristics and treatment response. We analysed the data on 2,593 operable BCPs age ≤50 years who were treated in the Cancer Hospital of Fudan University, Shanghai, China between 1990 and 2004. The overall survival and recurrence/metastasis-free survival were compared. In the study, 782 patients (30.2%) were ≤40 years, and 1,811 (69.8%) were 41–50 years old at their primary diagnosis. BCPs ≤40 years presented more unfavourable features than the 41–50 years BCPs (P < 0.05). They were more likely to experience death (P < 0.001) and recurrence/metastasis events (P < 0.001) even when they underwent the same adjuvant therapy in parallel with their counterparts (P < 0.05). In a multivariate analysis, age was an independent predictive factor for RFS (HR = 0.26, 95% CI = 0.44–0.89, P = 0.009) but not for OS (P > 0.05). Higher TNM stage and chemotherapy, but not HER2/neu over-expression, were predictive factors for young Chinese BCPs. The characteristics of breast cancer are more aggressive in young Chinese BCPs. Their prognostic factors are obviously different from those of the elder group. Current therapy was not as effective for them.

Keywords

Breast cancer Characteristics Survival Therapy Young women 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

The authors thank the patients for their willingness to cooperate with our study. This research was supported in part by the grants from the Shanghai Science and Technology Committee (06DJ14004, 06DZ19504).

References

  1. 1.
    Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71–96CrossRefPubMedGoogle Scholar
  2. 2.
    Fan L, Zheng Y, Yu KD, Liu GY, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM (2009) Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat 117:409–416Google Scholar
  3. 3.
    Brinton LA, Sherman ME, Carreon JD, Anderson WF (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100:1643–1648CrossRefPubMedGoogle Scholar
  4. 4.
    Colonna M, Delafosse P, Uhry Z, Poncet F, Arveux P, Molinie F, Cherie-Challine L, Grosclaude P (2008) Is breast cancer incidence increasing among young women? An analysis of the trend in France for the period 1983–2002. Breast 17:289–292CrossRefPubMedGoogle Scholar
  5. 5.
    Yankaskas BC (2005) Epidemiology of breast cancer in young women. Breast Dis 23:3–8PubMedGoogle Scholar
  6. 6.
    Ahn SH, Son BH, Kim SW, Kim SI, Jeong J, Ko SS, Han W (2007) Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea—a report from the Korean Breast Cancer Society. J Clin Oncol 25:2360–2368CrossRefPubMedGoogle Scholar
  7. 7.
    Axelrod D, Smith J, Kornreich D, Grinstead E, Singh B, Cangiarella J, Guth AA (2008) Breast cancer in young women. J Am Coll Surg 206:1193–1203CrossRefPubMedGoogle Scholar
  8. 8.
    Nixon AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S, Abner A, Recht A, Vicini F, Harris JR (1994) Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12:888–894PubMedGoogle Scholar
  9. 9.
    Rapiti E, Fioretta G, Verkooijen HM, Vlastos G, Schafer P, Sappino AP, Kurtz J, Neyroud-Caspar I, Bouchardy C (2005) Survival of young and older breast cancer patients in Geneva from 1990 to 2001. Eur J Cancer 41:1446–1452CrossRefPubMedGoogle Scholar
  10. 10.
    McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 97:1180–1184PubMedCrossRefGoogle Scholar
  11. 11.
    Dubsky PC, Gnant MF, Taucher S, Roka S, Kandioler D, Pichler-Gebhard B, Agstner I, Seifert M, Sevelda P, Jakesz R (2002) Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer. Clin Breast Cancer 3:65–72CrossRefPubMedGoogle Scholar
  12. 12.
    Sidoni A, Cavaliere A, Bellezza G, Scheibel M, Bucciarelli E (2003) Breast cancer in young women: clinicopathological features and biological specificity. Breast 12:247–250CrossRefPubMedGoogle Scholar
  13. 13.
    Maggard MA, O’Connell JB, Lane KE, Liu JH, Etzioni DA, Ko CY (2003) Do young breast cancer patients have worse outcomes? J Surg Res 113:109–113CrossRefPubMedGoogle Scholar
  14. 14.
    Vanlemmens L, Hebbar M, Peyrat JP, Bonneterre J (1998) Age as a prognostic factor in breast cancer. Anticancer Res 18:1891–1896PubMedGoogle Scholar
  15. 15.
    Goldhirsch A, Gelber RD, Yothers G, Gray RJ, Green S, Bryant J, Gelber S, Castiglione-Gertsch M, Coates AS (2001) Adjuvant therapy for very young women with breast cancer: need for tailored treatments. J Natl Cancer Inst Monogr 4:4–51Google Scholar
  16. 16.
    Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Orlando L, Ghisini R, Viale G, Pruneri G, Veronesi P, Luini A, Intra M, Cardillo A, Torrisi R, Rocca A, Goldhirsch A (2006) Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease. Ann Oncol 17:1497–1503CrossRefPubMedGoogle Scholar
  17. 17.
    Walker RA, Lees E, Webb MB, Dearing SJ (1996) Breast carcinomas occurring in young women (<35 years) are different. Br J Cancer 74:1796–1800PubMedGoogle Scholar
  18. 18.
    Albain KS, Allred DC, Clark GM (1994) Breast cancer outcome and predictors of outcome: are there age differentials? J Natl Cancer Inst Monogr 3:5–42Google Scholar
  19. 19.
    Yu KD, Di GH, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM (2007) Development and trends of surgical modalities for breast cancer in China: a review of 16-year data. Ann Surg Oncol 14:2502–2509CrossRefPubMedGoogle Scholar
  20. 20.
    Aebi S, Gelber S, Castiglione-Gertsch M, Gelber RD, Collins J, Thurlimann B, Rudenstam CM, Lindtner J, Crivellari D, Cortes-Funes H, Simoncini E, Werner ID, Coates AS, Goldhirsch A (2000) Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet 355:1869–1874CrossRefPubMedGoogle Scholar
  21. 21.
    Colleoni M, Rotmensz N, Robertson C, Orlando L, Viale G, Renne G, Luini A, Veronesi P, Intra M, Orecchia R, Catalano G, Galimberti V, Nole F, Martinelli G, Goldhirsch A (2002) Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 13:273–279CrossRefPubMedGoogle Scholar
  22. 22.
    Han W, Kim SW, Park IA, Kang D, Youn YK, Oh SK, Choe KJ, Noh DY (2004) Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 4:82CrossRefPubMedGoogle Scholar
  23. 23.
    Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ (2007) Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18:1133–1144CrossRefPubMedGoogle Scholar
  24. 24.
    de la Rochefordiere A, Asselain B, Campana F, Scholl SM, Fenton J, Vilcoq JR, Durand JC, Pouillart P, Magdelenat H, Fourquet A (1993) Age as prognostic factor in premenopausal breast carcinoma. Lancet 341:1039–1043CrossRefGoogle Scholar
  25. 25.
    Bonnier P, Romain S, Charpin C, Lejeune C, Tubiana N, Martin PM, Piana L (1995) Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 62:138–144CrossRefPubMedGoogle Scholar
  26. 26.
    Love RR, Duc NB, Dinh NV, Quy TT, Xin Y, Havighurst TC (2002) Young age as an adverse prognostic factor in premenopausal women with operable breast cancer. Clin Breast Cancer 2:294–298CrossRefPubMedGoogle Scholar
  27. 27.
    Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M (2000) Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 320:474–478CrossRefPubMedGoogle Scholar
  28. 28.
    van‘t Veer LI, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536CrossRefGoogle Scholar
  29. 29.
    Klauber-DeMore N (2005) Tumor biology of breast cancer in young women. Breast Dis 23:9–15PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2009

Authors and Affiliations

  • Li-Chen Tang
    • 1
  • Wen-Jin Yin
    • 1
  • Gen-Hong Di
    • 1
  • Zhen-Zhou Shen
    • 1
  • Zhi-Ming Shao
    • 1
  1. 1.Department of Oncology, Shanghai Medical College, Breast Cancer Institute, Cancer Hospital/Cancer InstituteFudan UniversityShanghaiPeople’s Republic of China

Personalised recommendations